查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1339159

研究機構非人靈長類動物臨床前測試的全球市場、份額、規模、趨勢和行業分析報告：按應用、地區和細分市場預測，2023-2032 年

Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Share, Size, Trends, Industry Analysis Report, By Application (Infectious Disease, Immunological Disease, Cancer, Others) By Region; Segment Forecast, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，研究機構的非人靈長類動物臨床前測試市場預計到 2032 年將達到 108,553,860 美元。該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

世界各地的研究機構對非人靈長類動物進行臨床前測試是開發新藥和疫苗的重要一步，CRO 為進行此類測試提供了經濟高效的解決方案。基因組學和其他技術的最新進展提高了我們對非人靈長類動物生物學的理解，並促進了它們在臨床前研究中的使用。然而，在研究中使用非人類靈長類動物仍然存在爭議，開發非動物臨床前測試的替代品的趨勢日益明顯。

基因組學和其他技術的最新進展加深了我們對非人類靈長類動物的生物學理解，並改善了用於轉化研究的非人類靈長類動物模型的開發。這些進步也促進了非人靈長類動物在臨床前測試中的使用，從而可以對新藥和疫苗的安全性和有效性進行更全面的評估。

在北美 CRO 進行的非人靈長類動物臨床前測試已成為藥物開發的重要一步。新技術的整合和非人靈長類動物模型的升級用於轉化研究，提高了非人靈長類臨床前測試的準確性和有效性。

儘管由於倫理問題，在非臨床研究中使用非人靈長類動物仍然存在爭議，但 CRO 已經制定了嚴格的倫理準則和法規，以確保研究中使用的動物的福祉。我們遵守以下規定。此外，CRO 與監管機構密切合作，確保臨床前研究在進行臨床試驗之前滿足安全性和有效性要求。

歐洲 CRO 遵循嚴格的道德準則和法規，以確保動物福利，監管機構負責監督臨床前研究的安全性和有效性。儘管在非臨床研究中使用非人類靈長類動物仍然存在爭議，但這些測試仍然是藥物開發的重要步驟。

升級非人類靈長類動物模型用於轉化研究的趨勢日益明顯，重點是使用具有特定疾病表型的非人靈長類動物。例如，開發了阿茲海默症、帕金森氏症和愛滋病毒感染的非人靈長類動物模型，以便更好地了解這些疾病的發病機制並測試新的治療方法。

然而，在臨床前測試中使用非人靈長類動物仍然存在爭議，動物權利活動人士繼續提出對動物福利的擔憂。許多組織呼籲開發不涉及動物的臨床前測試的替代方案。

全球市場研究報告重點介紹研究機構中的非人靈長類動物臨床前測試

人們對使用基於非人靈長類動物（非人靈長類動物）的臨床前研究進行研究的興趣日益濃厚，是該領域增長的主要驅動力。

在北美，研究機構定期對非人靈長類動物進行臨床前研究，以進行研究和開發以及跨中心鑑定具有特定表型的動物群體，並且這些研究正在顯著增長。

目錄

第 1 章 簡介

第二章執行摘要

第三章研究方法論

第 4 章：全球研究機構非人類靈長類動物臨床前測試的市場洞察

  • 研究機構中的非人靈長類動物臨床前測試市場—產業概況
  • 研究機構非人靈長類臨床前測試市場動態
    • 驅動因素和機遇
      • CRISPR 技術的創新導致非人類靈長類動物臨床前試驗的採用增加
      • 老年人口增加和目標疾病盛行率上升
    • 限制因素和挑戰
      • 存在高昂的程序成本和模糊的監管框架
  • PESTLE分析
  • 價值鏈分析
  • 非人靈長類合約研究機構臨床前研究產業趨勢
  • COVID-19 感染的影響分析

第五章 全球研究機構非人靈長類臨床前測試市場（按應用）

  • 主要發現
  • 介紹
  • 感染
  • 免疫性疾病
  • 癌症
  • 心血管疾病
  • 代謝性疾病
  • 遺傳病
  • 呼吸系統疾病
  • 神經系統疾病
  • 與婦女有關的疾病
  • 其他

第六章 全球研究機構非人靈長類動物臨床前測試市場（按地區）

  • 主要發現
  • 介紹
    • 2019-2032 年研究機構市場評估中的非人靈長類動物臨床前測試（按地區）
  • 研究機構的非人靈長類臨床前測試市場—北美
    • 北美：研究機構非人類靈長類動物臨床前測試市場（按應用），2019-2032
    • 研究機構的非人靈長類動物臨床前測試市場—美國
    • 研究機構的非人靈長類動物臨床前測試市場—加拿大
  • 研究機構的非人靈長類動物臨床前測試市場—歐洲
    • 歐洲：研究機構的非人類靈長類動物臨床前測試市場，按應用劃分，2019-2032
    • 研究機構的非人靈長類動物臨床前測試市場—英國
    • 研究機構的非人靈長類動物臨床前測試市場—法國
    • 研究機構的非人靈長類動物臨床前測試市場—德國
    • 研究機構的非人靈長類動物臨床前測試市場—義大利
    • 研究機構的非人靈長類動物臨床前測試市場—西班牙
    • 研究機構的非人靈長類動物臨床前測試市場—荷蘭
    • 研究機構的非人靈長類動物臨床前測試市場—奧地利
  • 研究機構的非人靈長類動物臨床前測試市場 - 亞太地區
    • 亞太地區：研究機構中的非人靈長類動物臨床前測試市場（按應用劃分），2019-2032
    • 研究機構的非人靈長類臨床前測試市場—中國
    • 研究機構的非人靈長類動物臨床前測試市場—印度
    • 研究機構的非人靈長類動物臨床前測試市場—馬來西亞
    • 研究機構的非人靈長類動物臨床前測試市場—日本
    • 研究機構的非人靈長類動物臨床前測試市場—印度尼西亞
    • 研究機構的非人靈長類動物臨床前測試市場—韓國
  • 研究機構的非人靈長類臨床前測試市場—中東和非洲
    • 中東和非洲：研究機構非人類靈長類動物臨床前測試市場（按應用），2019-2032
    • 研究機構的非人靈長類臨床前測試市場—沙烏地阿拉伯
    • 研究機構的非人靈長類動物臨床前測試市場—阿聯酋
    • 研究機構的非人靈長類動物臨床前測試市場—以色列
    • 研究機構的非人靈長類動物臨床前測試市場—南非
  • 研究機構的非人靈長類動物臨床前測試市場—拉丁美洲
    • 拉丁美洲：研究機構中的非人類靈長類動物臨床前測試市場（按應用），2019-2032
    • 研究機構的非人靈長類動物臨床前測試市場—墨西哥
    • 研究機構的非人靈長類動物臨床前測試市場—巴西
    • 研究機構的非人靈長類動物臨床前測試市場—阿根廷

第七章 競爭格局

  • 擴張和收購分析
    • 擴張
    • 獲得
  • 夥伴關係/協作/協議/揭露

第八章公司簡介

  • ABL, Inc
  • Applied BioCode Corporation
  • BioLegend, Inc
  • Exocell, Inc
  • HUREL Corporation
  • iQ Biosciences
  • Mabtech AB
Product Code: PM3539

The Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market size is expected to reach USD 1,08,553.86 thousands by 2032, according to a new study by Polaris Market Research. The report "Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Share, Size, Trends, Industry Analysis Report, By Application (Infectious Disease, Immunological Disease, Cancer, Others) By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Global NHP pre-clinical studies are an essential step in the development of new drugs and vaccines, and CROs provide a cost-effective solution for conducting such studies. Recent advances in genomics and other technologies have improved our understanding of NHP biology and facilitated the use of NHPs in pre-clinical studies. However, the use of NHPs in research remains controversial, and there is a growing trend toward the development of alternative methods for pre-clinical testing that do not involve the use of animals.

Recent advances in genomics and other technologies have enabled a better understanding of NHP biology and improved the development of NHP models for translational research. These advances have also facilitated the use of NHPs in pre-clinical studies, allowing for a more comprehensive assessment of the safety and efficacy of new drugs and vaccines.

NHPs in pre-clinical studies at CROs in North America has become an essential step in drug development. The integration of new technologies and the upgradation of NHP models for translational research have improved the accuracy and efficacy of NHP pre-clinical studies.

While the use of NHPs in pre-clinical studies remains controversial due to ethical concerns, CROs adhere to strict ethical guidelines and regulations to ensure the welfare of animals used in research. Additionally, CROs work closely with regulatory agencies to ensure that the pre-clinical studies meet safety and efficacy requirements before advancing to clinical trials.

CROs in Europe follow strict ethical guidelines and regulations to ensure animal welfare and regulatory agencies oversee the safety and efficacy of pre-clinical studies. While the use of NHPs in pre-clinical studies remains controversial, these studies remain an essential step in drug development.

There is a growing trend towards the upgradation of NHP models for translational research, with more focus on using NHPs that have specific disease phenotypes. For example, NHP models of Alzheimer's disease, Parkinson's disease, and HIV infection have been developed to better understand the pathogenesis of these diseases and test new treatments.

However, the use of NHPs in pre-clinical studies remains controversial, and animal rights activists continue to voice their concerns about animal welfare. Many organizations have called for the development of alternative methods for pre-clinical testing that do not involve the use of animals.

Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Report Highlights

The increasing interest in using non-human primate (NHP) based preclinical trials for research purposes has led to a significant boost in the growth of this segment.

North America witnesses the significant growth for the Non-Human Primate Pre-clinical studies at Contract Research Organizations periodically for the development and to identify cohorts of animals with specific phenotypes across centers.

The global players include: ABL, Inc., Applied BioCode Corporation, BioLegend, Inc., Exocell, Inc., HUREL Corporation, iQ Biosciences, and Mabtech AB, among others.

Polaris Market Research has segmented the Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market report based on Application and Region:

Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market,

Application Outlook (Revenue, USD Thousands, 2019-2032)

  • Infectious Disease
  • Immunological Disease
  • Cancer
  • Cardiovascular Disease
  • Metabolic Diseases
  • Genetic Disease
  • Respiratory Diseases
  • Neurological Disease
  • Female Related Diseases
  • Others

Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, Regional Outlook (Revenue - USD Thousands, 2019-2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Insights

  • 4.1. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Industry Snapshot
  • 4.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Innovations in CRISPR technologies leading to increased adoption in NHP preclinical trials
      • 4.2.1.2. Rising Geriatric Population and Rising Prevalence of Target Diseases
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Procedure Costs and Presence of Ambiguous Regulatory Framework
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Value Chain Analysis
  • 4.6. Non-Human Primate Pre-clinical studies at Contract Research Organizations Industry trends
  • 4.7. COVID-19 Impact Analysis

5. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • 5.3. Infectious Disease
    • 5.3.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Infectious Disease, by Region, 2019-2032 (USD Million)
  • 5.4. Immunological Disease
    • 5.4.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Immunological Disease, by Region, 2019-2032 (USD Million)
  • 5.5. Cancer
    • 5.5.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Cancer, by Region, 2019-2032 (USD Million)
  • 5.6. Cardiovascular Disease
    • 5.6.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Cardiovascular Disease, by Region, 2019-2032 (USD Million)
  • 5.7. Metabolic Diseases
    • 5.7.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Metabolic Diseases, by Region, 2019-2032 (USD Million)
  • 5.8. Genetic Disease
    • 5.8.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Genetic Disease, by Region, 2019-2032 (USD Million)
  • 5.9. Respiratory Diseases
    • 5.9.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Respiratory Diseases, by Region, 2019-2032 (USD Million)
  • 5.10. Neurological Disease
    • 5.10.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Neurological Disease, by Region, 2019-2032 (USD Million)
  • 5.11. Female Related Diseases
    • 5.11.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Female Related Diseases, by Region, 2019-2032 (USD Million)
  • 5.12. Others
    • 5.12.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Geography

  • 6.1. Key findings
  • 6.2. Introduction
    • 6.2.1. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Assessment, By Geography, 2019-2032 (USD Million)
  • 6.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - North America
    • 6.3.1. North America: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.3.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - U.S.
      • 6.3.2.1. U.S.: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.3.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Canada
      • 6.3.3.1. Canada: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • 6.4. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Europe
    • 6.4.1. Europe: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.4.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - UK
      • 6.4.2.1. UK: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.4.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - France
      • 6.4.3.1. France: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.4.4. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Germany
      • 6.4.4.1. Germany: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.4.5. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Italy
      • 6.4.5.1. Italy: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.4.6. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Spain
      • 6.4.6.1. Spain: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.4.7. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Netherlands
      • 6.4.7.1. Netherlands: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.4.8. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Austria
      • 6.4.8.1. Austria: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • 6.5. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Asia Pacific
    • 6.5.1. Asia Pacific: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.5.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - China
      • 6.5.2.1. China: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.5.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - India
      • 6.5.3.1. India: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.5.4. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Malaysia
      • 6.5.4.1. Malaysia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.5.5. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Japan
      • 6.5.5.1. Japan: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.5.6. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Indonesia
      • 6.5.6.1. Indonesia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.5.7. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - South Korea
      • 6.5.7.1. South Korea: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • 6.6. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Middle East & Africa
    • 6.6.1. Middle East & Africa: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.6.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Saudi Arabia
      • 6.6.2.1. Saudi Arabia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.6.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - UAE
      • 6.6.3.1. UAE: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.6.4. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Israel
      • 6.6.4.1. Israel: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.6.5. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - South Africa
      • 6.6.5.1. South Africa: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • 6.7. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Latin America
    • 6.7.1. Latin America: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.7.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Mexico
      • 6.7.2.1. Mexico: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.7.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Brazil
      • 6.7.3.1. Brazil: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.7.4. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Argentina
      • 6.7.4.1. Argentina: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)

7. Competitive Landscape

  • 7.1. Expansion and Acquisition Analysis
    • 7.1.1. Expansion
    • 7.1.2. Acquisitions
  • 7.2. Partnerships/Collaborations/Agreements/Exhibitions

8. Company Profiles

  • 8.1. ABL, Inc
    • 8.1.1. Company Overview
    • 8.1.2. Financial Performance
    • 8.1.3. Product Benchmarking
    • 8.1.4. Recent Development
  • 8.2. Applied BioCode Corporation
    • 8.2.1. Company Overview
    • 8.2.2. Financial Performance
    • 8.2.3. Product Benchmarking
    • 8.2.4. Recent Development
  • 8.3. BioLegend, Inc
    • 8.3.1. Company Overview
    • 8.3.2. Financial Performance
    • 8.3.3. Product Benchmarking
    • 8.3.4. Recent Development
  • 8.4. Exocell, Inc
    • 8.4.1. Company Overview
    • 8.4.2. Financial Performance
    • 8.4.3. Product Benchmarking
    • 8.4.4. Recent Development
  • 8.5. HUREL Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Financial Performance
    • 8.5.3. Product Benchmarking
    • 8.5.4. Recent Development
  • 8.6. iQ Biosciences
    • 8.6.1. Company Overview
    • 8.6.2. Financial Performance
    • 8.6.3. Product Benchmarking
    • 8.6.4. Recent Development
  • 8.7. Mabtech AB
    • 8.7.1. Company Overview
    • 8.7.2. Financial Performance
    • 8.7.3. Product Benchmarking
    • 8.7.4. Recent Development

List of Tables

  • Table 1 Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 2 Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 3 North America: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 4 U.S.: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 5 Canada: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 6 Canada: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 7 Europe: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 8 Spain: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 9 Netherlands: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 10 Austria: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 11 Germany: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 12 Italy: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 13 France: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 14 Asia Pacific: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 15 China: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 16 Japan: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 17 India: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 18 Indonesia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 19 South Korea: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 20 Malaysia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 21 Latin America: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 22 Brazil: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 23 Mexico: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 24 Argentina: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 25 Middle East & Africa: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 26 South Africa: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 27 Israel: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 28 Saudi Arabia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 29 UAE: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)

List of Figures

  • Figure 1 Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, 2019-2032 (USD Million)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Application
  • Figure 7 Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2022 & 2032 (USD Million)
  • Figure 8 Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 9 Strategic Analysis - Non-Human Primate Pre-clinical studies at Contract Research Organizations Market